Lambros T. Koufariotis

300 Herston Road
Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.

Journal: BMC cancer
Published: March 09, 2026

Explainable machine learning identifies features and thresholds predictive of immunotherapy response.

Explainable machine learning identifies features and thresholds predictive of immunotherapy response.

Journal: Scientific reports
Published: October 17, 2025

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities.

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities.

Journal: Genome medicine
Published: October 11, 2025

Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification.

Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification.

Journal: EBioMedicine
Published: June 28, 2025

Cancer genome standards for long-read sequencing using cancer cell line mixtures.

Cancer genome standards for long-read sequencing using cancer cell line mixtures.

Journal: GigaScience
Published: May 06, 2025

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

Journal: Cancer cell
Published: February 07, 2025

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology.

Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology.

Journal: BMC genomics
Published: March 01, 2024

Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing.

Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing.

Journal: Cancers
Published: December 22, 2023

Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy.

Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy.

Journal: Genome medicine
Published: December 12, 2023

The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.

The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.

Journal: Frontiers in immunology
Published: May 10, 2023

Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.

Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.

Journal: The Journal of molecular diagnostics : JMD
Published: April 03, 2023

IL-10-producing Th1 cells possess a distinct molecular signature in malaria.

IL-10-producing Th1 cells possess a distinct molecular signature in malaria.

Journal: The Journal of clinical investigation
Published: February 14, 2023
Showing 1-12 of 44

Last Updated: 09/26/2026